By redefining the power of small molecules to control the expression of genes, we aim to develop medicines that provide a profound benefit for patients.
Location: United States, Massachusetts, Cambridge
Member count: 51-200
Total raised: $123M
Founded date: 2011
Investors 5
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Omega Fund... | omegafunds... |
| - | 6 Dimensio... | 6dimension... |
| 04.10.2022 | Bain Capit... | baincapita... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 12.01.2016 | - | $40M | - | finsmes.co... |
| 27.10.2014 | Series B | $53M | - | aislingcap... |
| 12.04.2013 | Series A | $30M | - | finsmes.co... |
Mentions in press and media 26
| Date | Title | Description | Category | Author | Source |
| 23.06.2022 | Syros Phar... | “Genedata Profiler’s unique ap... | - | - | prweb.com/... |
| 07.12.2020 | Ally Bridg... | Oral Arsenic Trioxide has Pote... | - | - | ally-bridg... |
| 17.10.2019 | Syros eyes... | Shares of Syros were down 32.3... | - | - | medcitynew... |
| 17.10.2019 | PhI fizzl... | Less than stellar Phase I re... | - | Amber Tong | endpts.com... |
| 26.04.2017 | Syros Clos... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
| 15.01.2016 | Syros rais... | Syros CEO Dr. Nancy Simonian ... | Venture Ca... | - | fiercebiot... |
| 13.01.2016 | Syros Phar... | Syros Pharmaceuticals, a Cambr... | USA | - | finsmes.co... |
| 13.01.2016 | Syros Phar... | CAMBRIDGE, MA, Syros Pharmac... | - | - | vcnewsdail... |
| 13.01.2016 | Daily fund... | Zerto secured $50M; Syros Phar... | - | Mitos Suso... | vator.tv/n... |
| 12.01.2016 | Syros Phar... | – Company Advancing Pipeline o... | - | - | aislingcap... |
Show more